Living Cell Technologies Granted European Patent for Neurological Disease Product NTCELL
20 January, 2010 by Staff WritersLiving Cell Technologies has been granted a European patent for the use of its product NTCELL in the treatment of degenerative neurological conditions.
Mesoblast generates impressive gains over Christmas
11 January, 2010 by Tim DeanMesoblast generates impressive gains over Christmas.
Unravelling kidney cancer
07 January, 2010 by Staff WritersMutations in the genome regulation machinery identified in clear cell renal cell carcinoma.
Majority of Australians shun H1N1 vaccine
05 January, 2010 by Tim DeanMany Australians confused or concerned about the swine flu vaccine. Health experts concerned about continued spread.
Gene linked to schizophrenia and bipolar disorder
16 December, 2009 by Staff WritersGene, ABCA13, has been found to be linked to schizophrenia and bipolar disorder.
Feature: Turning toxins against MS
11 December, 2009 by Graeme O'NeillThe Caribbean sun anemone disables its prey with a potent neurotoxin that could provide a new treatment for the disabling auto-immune disorder, multiple sclerosis.
Gene therapy and stem cells save limb
09 December, 2009 by Staff WritersTreatment could help improve blood flow and decrease tissue death in individuals with diabetes.
Xenotransplantation patient less reliant on insulin
07 December, 2009 by Tim DeanFirst patient to receive Living Cell Technology's Diabcell implant has reduced insulin dose.
New test finds chink in cancer's armour
24 November, 2009 by Tim DeanAustralian scientists develop rapid and easy assay that could lead to a new cancer tests and targeted chemotherapy drugs.
New kidney cancer drug gets TGA tick
19 November, 2009 by Tim DeanNovartis Australia has received Therapeutic Goods Administration approval for Afinitor.
Biotech Market Spotlight: QRxPharma and Living Cell Technology
16 November, 2009 by Tim DeanQRxPharma raises $21.6 m and Living Cell Technology offers share purchase plan.
Priority status granted to ChemGenex's leukaemia treatment
10 November, 2009 by Tim DeanFDA grants ChemGenex Priority Review for New Drug Application for Omapro.
Feature: ‘Gatekeeper’ protein protects injured brain
06 November, 2009 by Graeme O'NeillAfter a stroke or physical trauma, toxic metal ions flood into brain cells. Seong-Seng Tan has found a way to close the floodgates until the hazard passes.
Opinion: Biotechnology and the future of health
26 October, 2009 by Staff WritersBiotechnology promises untold benefits to humanity, but our mindsets are still stuck in the 20th century. Anna Lavelle stresses the need for change.
Feature: Multiplexing cancers of unknown primaries
13 October, 2009 by Kate McDonaldA new test under development could aid in the currently problematic diagnosis of cancers of unknown primary.
